NEOADJUVANT ABLATIVE RADIOEMBOLIZATION AS A METHOD OF PREPARATION FOR MAJOR HEPATECTOMY IN HIGH RISK PATIENTS.
Sacha Broccard*, Beau Toskich, Cristian Tarazona, Belisario Ortiz, John Stauffer
Mayo Clinic, Jacksonville, Ponte Vedra, FL
Ablative radioembolization is a method of hepatic conditioning that combines neoadjuvant radiotherapy along with inducing hypertrophy of planned future liver remnant to optimize high risk patients for major hepatic resection. Ablative radioembolization is given in a lobar dose over a 3-9 month time period. After a "test of biology" time period, patients without extra-hepatic metastatic involvement can more safely undergo major hepatic resection. Our video outlines an 86 year old male with 11 cm hepatocellular carcinoma. It displays ablative radioembolization performed twice followed by laparoscopic hand assisted right hepatectomy over 8 month period.
Back to 2020 Abstracts